Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients
Clinical trial NCT06408454 · COMPLETED
Trial details
- NCT number
- NCT06408454
- Sponsor
- Kahramanmaras Sutcu Imam University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-01
- Primary completion
- 2023-04-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.